MRK

#42
Merck & Company, Inc. Common Stock
118.7 4 USD
-0.74%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
118.22
119.67
Range Annuel
75.40
125.14
Changement quotidien
-0.74%
Changement Mensuel
+7.97%
Evolution sur 6 mois
+13.55%
Changement Annuel
+54.33%
Clôture Précédente
119.6 2
Open
119.6 5
Low
118.2 2
High
119.6 7
Volume
3 690
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques Dividendes
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur 202020212022202320242025 TTM

Merck & Company, Inc. Common Stock

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck".

Nouvelles